BISCOTTI, TOMMASINA
 Distribuzione geografica
Continente #
NA - Nord America 696
EU - Europa 331
AS - Asia 166
AF - Africa 32
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.245
Nazione #
US - Stati Uniti d'America 694
IT - Italia 74
UA - Ucraina 66
CN - Cina 48
SG - Singapore 46
SE - Svezia 39
IE - Irlanda 33
DE - Germania 31
RU - Federazione Russa 30
TR - Turchia 30
CI - Costa d'Avorio 28
DK - Danimarca 25
HK - Hong Kong 21
BR - Brasile 18
FI - Finlandia 18
KR - Corea 13
GB - Regno Unito 9
FR - Francia 5
IN - India 4
MA - Marocco 3
EU - Europa 2
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CR - Costa Rica 1
GA - Gabon 1
IQ - Iraq 1
JO - Giordania 1
PK - Pakistan 1
Totale 1.245
Città #
Chandler 101
Fairfield 80
Jacksonville 68
Ashburn 52
Seattle 39
Wilmington 36
Houston 35
Dublin 33
Cambridge 32
Singapore 32
Boardman 31
New York 31
Woodbridge 30
Abidjan 28
Hong Kong 21
Centro 17
Lawrence 14
Princeton 14
San Mateo 14
Porto 11
Ann Arbor 10
San Diego 9
Beijing 6
Cagliari 6
Guangzhou 6
Ancona 5
Chiaravalle 5
Moscow 5
Helsinki 4
Rome 4
Shanghai 4
The Dalles 4
Dallas 3
Kilburn 3
Pune 3
San Francisco 3
Turin 3
Wuhan 3
Boston 2
Des Moines 2
London 2
Macerata 2
São Paulo 2
Washington 2
Akanda 1
Amman 1
Aracaju 1
Arapongas 1
Arqua Petrarca 1
Baghdad 1
Baku 1
Baoding 1
Belford Roxo 1
Belo Horizonte 1
Birmingham 1
Cerquilho 1
Chennai 1
Chicago 1
Concórdia 1
Franca 1
Harbin 1
Islamabad 1
Istanbul 1
Jacutinga 1
Jequié 1
Jiangmen 1
Jiaxing 1
Jinan 1
Juazeiro do Norte 1
Kunming 1
Liberia 1
Los Angeles 1
Maracaí 1
Nanjing 1
Paranaguá 1
Perugia 1
Porto San Giorgio 1
Quanzhou 1
Rio das Ostras 1
San Jose 1
Shenzhen 1
Suzhou 1
São José dos Campos 1
Toronto 1
Tramandaí 1
Turku 1
Vienna 1
Wuhu 1
Xi'an 1
Yiwu 1
Totale 863
Nome #
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 124
Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection 116
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 113
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 103
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 96
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 95
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 88
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 88
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. 82
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 82
The Pathology of Breast Cancer 75
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 73
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. 72
analisi immunoistochimica e molecolare (CISH/FISH) dei fattori predittivi di risposta alla terapia irinotecan-cetuximab nel carcinoma del colon-retto in stadio avanzato 68
Totale 1.275
Categoria #
all - tutte 6.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 0 0 0 25
2020/2021313 15 33 26 1 65 40 20 18 17 40 26 12
2021/2022113 6 35 2 0 0 6 8 5 4 16 12 19
2022/2023229 15 38 14 19 30 26 0 7 62 3 12 3
2023/2024145 19 3 7 17 14 49 5 10 2 3 2 14
2024/2025239 57 24 6 13 14 17 11 11 52 15 19 0
Totale 1.275